Caudill Cortney (CIK 2090209) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy HALO (20,000 shares), Sell HALO (17,900 shares), Sell HALO (2,100 shares), Buy HALO (1,546 shares), Sell HALO (8,857 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Buy | 20,000 | $670,200 |
| 2026-03-10 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Sell | 17,900 | $1.2M |
| 2026-03-10 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Sell | 2,100 | $143,325 |
| 2026-03-10 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Buy | 1,546 | $51,806 |
| 2026-03-10 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Sell | 8,857 | $599,087 |
| 2026-02-24 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Buy | 2,666 | $0 |
| 2026-02-24 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Sell | 1,037 | $73,606 |
| 2025-12-19 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Buy | 9,326 | $0 |
| 2025-12-19 | HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | Sell | 4,263 | $277,905 |
Source: SEC Form 4 filings · as of 2026-03-10